Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger P Hollis

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Human Gene Therapy|August 20, 2009
Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon systemTeiko Sumiyoshi, Nathalia G Holt, Roger P Hollis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 25, 2006
Transient gene expression by nonintegrating lentiviral vectorsSarah J Nightingale, Roger P Hollis, Karen A Pepper, et al.
Experimental Hematology|September 20, 2006
Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposonRoger P Hollis, Sarah J Nightingale, Xiuli Wang, et al.
Stem Cells (Dayton, Ohio)|January 16, 2015
Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapyKismet Baldwin, Fabrizia Urbinati, Zulema Romero, et al.
Stem Cell Reports|November 13, 2020
β-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion ProductionJiaying Han, Kevin Tam, Feiyang Ma, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2024
A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell diseaseKevyn L Hart, Boya Liu, Devin Brown, et al.
Molecular Therapy. Methods & Clinical Development|December 12, 2018
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell DiseaseValentina Poletti, Fabrizia Urbinati, Sabine Charrier, et al.
Human Gene Therapy|September 11, 2018
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison StudyFabrizia Urbinati, Beatriz Campo Fernandez, Katelyn E Masiuk, et al.
Molecular Therapy. Nucleic Acids|January 30, 2017
Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted EndonucleasesCarmen F Bjurström, Michelle Mojadidi, John Phillips, et al.
Experimental Hematology|February 15, 2015
Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cellsFabrizia Urbinati, Phillip W Hargrove, Sabine Geiger, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Human Gene Therapy|August 20, 2009
Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon systemTeiko Sumiyoshi, Nathalia G Holt, Roger P Hollis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 25, 2006
Transient gene expression by nonintegrating lentiviral vectorsSarah J Nightingale, Roger P Hollis, Karen A Pepper, et al.
Experimental Hematology|September 20, 2006
Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposonRoger P Hollis, Sarah J Nightingale, Xiuli Wang, et al.
Stem Cells (Dayton, Ohio)|January 16, 2015
Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapyKismet Baldwin, Fabrizia Urbinati, Zulema Romero, et al.
Stem Cell Reports|November 13, 2020
β-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion ProductionJiaying Han, Kevin Tam, Feiyang Ma, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2024
A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell diseaseKevyn L Hart, Boya Liu, Devin Brown, et al.
Molecular Therapy. Methods & Clinical Development|December 12, 2018
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell DiseaseValentina Poletti, Fabrizia Urbinati, Sabine Charrier, et al.
Human Gene Therapy|September 11, 2018
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison StudyFabrizia Urbinati, Beatriz Campo Fernandez, Katelyn E Masiuk, et al.
Molecular Therapy. Nucleic Acids|January 30, 2017
Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted EndonucleasesCarmen F Bjurström, Michelle Mojadidi, John Phillips, et al.
Experimental Hematology|February 15, 2015
Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cellsFabrizia Urbinati, Phillip W Hargrove, Sabine Geiger, et al.
Pageof 5